skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,887  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: Clinical Medicine remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Material Type:
Article 		Add to My Research

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2019-09, Vol.74 (10), p.1376-1414 [Peer Reviewed Journal]

2019. American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.009 ;PMID: 30894319

Full text available

Citations Cited by
2
Cardiovascular Safety of Testosterone-Replacement Therapy
Cardiovascular Safety of Testosterone-Replacement Therapy
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Testosterone-Replacement Therapy

The New England journal of medicine, 2023-07, Vol.389 (2), p.107-117 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2215025 ;PMID: 37326322

Full text available

Citations Cited by
3
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
Material Type:
Article 		Add to My Research

Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease

PloS one, 2021-12, Vol.16 (12), p.e0260839-e0260839 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Weng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Weng et al 2021 Weng et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0260839 ;PMID: 34855879

Full text available

Citations Cited by
4
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
Material Type:
Article 		Add to My Research

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

The Lancet (British edition), 2022-09, Vol.400 (10354), p.733-743 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01349-6 ;PMID: 36041475

Full text available

Citations Cited by
5
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis
Material Type:
Article 		Add to My Research

Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1522-1529 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-220577 ;PMID: 34215644

Full text available

Citations Cited by
6
Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis
Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis
Material Type:
Article 		Add to My Research

Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis

PloS one, 2015-03, Vol.10 (3), p.e0118504-e0118504 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;2015 Melillo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Melillo et al 2015 Melillo et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0118504 ;PMID: 25793605

Full text available

Citations Cited by
7
SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance
SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance
Material Type:
Article 		Add to My Research

SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance

Journal of cardiovascular magnetic resonance, 2020-11, Vol.22 (1), p.76-76, Article 76 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1532-429X ;ISSN: 1097-6647 ;EISSN: 1532-429X ;DOI: 10.1186/s12968-020-00682-4 ;PMID: 33161900

Full text available

Citations Cited by
8
Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study
Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study
Material Type:
Article 		Add to My Research

Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study

PloS one, 2015-12, Vol.10 (12), p.e0144182-e0144182 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Ren et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Ren et al 2015 Ren et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0144182 ;PMID: 26636669

Full text available

Citations Cited by
9
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Material Type:
Article 		Add to My Research

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

The Lancet (British edition), 2017-06, Vol.389 (10088), p.2473-2481 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 24, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31075-9 ;PMID: 28476288

Full text available

Citations Cited by
10
Postprandial Hyperglycemia and Glycemic Variability: Should we care?
Postprandial Hyperglycemia and Glycemic Variability: Should we care?
Material Type:
Article 		Add to My Research

Postprandial Hyperglycemia and Glycemic Variability: Should we care?

Diabetes care, 2011-05, Vol.34 (5), p.S120-S127 [Peer Reviewed Journal]

COPYRIGHT 2011 American Diabetes Association ;Copyright American Diabetes Association May 2011 ;2011 by the American Diabetes Association. 2011 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc11-s206 ;PMID: 21525442 ;CODEN: DICAD2

Full text available

Citations Cited by
11
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Material Type:
Article 		Add to My Research

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Drug safety, 2021-08, Vol.44 (8), p.899-915 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;Copyright Springer Nature B.V. Aug 2021 ;ISSN: 0114-5916 ;ISSN: 1179-1942 ;EISSN: 1179-1942 ;DOI: 10.1007/s40264-021-01095-7 ;PMID: 34236595

Full text available

Citations Cited by
12
Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes
Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes
Material Type:
Article 		Add to My Research

Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes

PloS one, 2016-10, Vol.11 (10), p.e0164807-e0164807 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Cha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Cha et al 2016 Cha et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0164807 ;PMID: 27741306

Full text available

Citations Cited by
13
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Material Type:
Article 		Add to My Research

Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study

BMJ (Online), 2018-05, Vol.361, p.k1786-k1786 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k1786 ;PMID: 29792314

Full text available

Citations Cited by
14
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
Material Type:
Article 		Add to My Research

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk

Heart (British Cardiac Society), 2023-08, Vol.109 (16), p.1216-1222 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. 2023 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2023-322431 ;PMID: 37080767

Full text available

Citations Cited by
15
Predicting atrial fibrillation in primary care using machine learning
Predicting atrial fibrillation in primary care using machine learning
Material Type:
Article 		Add to My Research

Predicting atrial fibrillation in primary care using machine learning

PloS one, 2019-11, Vol.14 (11), p.e0224582-e0224582 [Peer Reviewed Journal]

COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Hill et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Hill et al 2019 Hill et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0224582 ;PMID: 31675367

Full text available

Citations Cited by
16
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
Material Type:
Article 		Add to My Research

PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations

BMJ (Online), 2022-05, Vol.377, p.e069066-e069066 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2022BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-069066 ;PMID: 35508320

Full text available

Citations Cited by
17
Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
Material Type:
Article 		Add to My Research

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases

Heart (British Cardiac Society), 2016-03, Vol.102 (5), p.383-389 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2015-308514 ;PMID: 26786818

Full text available

Citations Cited by
18
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis
Material Type:
Article 		Add to My Research

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis

Annals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1414-1422 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217653 ;PMID: 32859608

Full text available

Citations Cited by
19
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Material Type:
Article 		Add to My Research

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

The Lancet (British edition), 2022-02, Vol.399 (10326), p.719-728 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02001-8 ;PMID: 35101175

Full text available

Citations Cited by
20
Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review
Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review
Material Type:
Article 		Add to My Research

Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review

Arthritis research & therapy, 2019-01, Vol.21 (1), p.33-33, Article 33 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1817-y ;PMID: 30670075

Full text available

Citations Cited by

Results 1 - 20 of 2,887  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1996  (9)
  2. 1996 To 2002  (18)
  3. 2003 To 2009  (158)
  4. 2010 To 2017  (643)
  5. After 2017  (2,067)
  6. More options open sub menu

Language 

  1. English  (2,886)
  2. Japanese  (138)
  3. Norwegian  (14)
  4. French  (2)
  5. Turkish  (2)
  6. Swedish  (1)
  7. Italian  (1)
  8. German  (1)
  9. Chinese  (1)
  10. Portuguese  (1)
  11. Bulgarian  (1)
  12. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait